Earlier this year, a surprising story emerged about RFK Jr. — the newly named nominee for secretary of the Department of ...
Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...